PHS
ATHN

PFM Health Sciences’s Athenahealth, Inc. ATHN Stock Holding History

PFM Health Sciences’s Portfolio ATHN Stock Details ATHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-342,540
Closed -$38.6M – 123
2017
Q1 		$38.6M Buy
+342,540
New +$39.9M 0.97% 44
2015
Q2 		– Sell
-106,714
Closed -$12.7M – 118
2015
Q1 		$12.7M Buy
+106,714
New +$14.2M 0.35% 68

Other funds holding ATHN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PFM Health Sciences's ATHN Position: Q2 2017 in Review

PFM Health Sciences sold out of Athenahealth, Inc. (ATHN) in Q2 2017, closing a stake of 342,540 shares — an estimated $38.6M sold.

PFM Health Sciences first reported a position in ATHN in Q1 2015 and held it in 2 quarters. The position peaked at $38.6M in Q1 2017. 226 funds tracked by Wall St. Rank hold ATHN as of Q2 2017.

  • PFM Health Sciences reported no remaining Athenahealth, Inc. position as of Q2 2017 after selling out during the quarter.
  • PFM Health Sciences sold 342,540 Athenahealth, Inc. shares in Q2 2017, an estimated $38.6M.
  • PFM Health Sciences first reported a position in Athenahealth, Inc. in Q1 2015 and held it in 2 quarters.
  • PFM Health Sciences's Athenahealth, Inc. position peaked at $38.6M in Q1 2017.
  • 226 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q2 2017.

Based on PFM Health Sciences's 13F filing for Q2 2017, filed 14 Aug 2017.